Clinical results from two prospective, randomized, controlled studies at the University of Zurich document neurologic improvement and tumor shrinkage in dogs with intracranial neoplasia. Collected by Carla Rohrer Bley, the data tracks treatment responses across all breeds and ages following radiotherapy for primary brain tumors. The dataset was last updated in March 2026.
Use Cases
- Statistical replication of neurologic improvement rates in dogs post-radiotherapy
- Modeling tumor shrinkage outcomes based on imaging-based diagnosis
- Comparative analysis of radiotherapy efficacy across different canine breeds and ages
Strengths
- Data sourced from two prospective, randomized, controlled, parallel-group studies
- Includes diverse canine demographics across all breeds, ages, and sexes
- Clinical findings from a specialized veterinary oncology and radiation clinic
Limitations
- Single-center study design limited to the University of Zurich
- Unknown sample size and record count
- Restricted to primary intracranial neoplasia cases
Provenance
- Source
- Clinic for Radiation Oncology & Medical Oncology, Vetsuisse Faculty, University of Zurich
- Collection Method
- Prospective, randomized, controlled, parallel-group clinical studies
- Freshness
- Last updated March 2026
- Geography
- Switzerland